Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 98 matching records.
98 results — page 1 of 5
- Level DNarrative ReviewEurope PMC
Perianal Crohn's Disease in Inflammatory Bowel Disease: Diagnosis, Assessment and Treatment
Narrative Review on Autoimmune Research, published in Life (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Life (Basel) - Level DAnimal StudyPubMed
ACSS2-mediated lysine crotonylation attenuates senescence and enhances the therapeutic efficacy of adipose-derived stem cells in inflammatory bowel disease.
Animal Study on Chronic Inflammation, published in Cell Regen (2026) — summary generated from the PubMed abstract.
- 2026
Cell Regen1 citations - Level BClinical TrialEurope PMC
Mapping the landscape and future directions of stem cell therapy for inflammatory bowel disease
Clinical Trial on Scar, Autoimmune Research, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DNarrative ReviewPubMed
Mesenchymal Stem Cells Derived Extracellular Vesicles in Inflammatory Bowel Disease: Therapeutic Efficacy and Bioengineering Applications.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine - Level DNarrative ReviewEurope PMC
Mesenteric adipose tissue: from protective gatekeeper to driver of inflammatory bowel disease
Narrative Review on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Immunometabolism (Cobham) (2026) — summary generated from the PubMed abstract.
- 2026
Immunometabolism (Cobham) - Level DNarrative ReviewEurope PMC
Exosomes in Inflammatory Bowel Disease: Mechanisms, Diagnostic Potential, and Engineering Strategies for Precision Therapy
Narrative Review on Immune Modulation, published in Int J Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Med Sci - Level ASystematic ReviewEurope PMC
Surgical interventions in inflammatory bowel disease: Indications, techniques, outcomes, and future directions
Systematic Review on Autoimmune Research, published in World J Gastrointest Pharmacol Ther (2026) — summary generated from the PubMed abstract.
- 2026
World J Gastrointest Pharmacol Ther - Level DAnimal StudyPubMed
Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease.
Animal Study on Chronic Inflammation, published in Theranostics (2025) — summary generated from the PubMed abstract.
- 2025
Theranostics - Level DNarrative ReviewEurope PMC
Angiogenic Factors and Inflammatory Bowel Diseases
Narrative Review on Chronic Inflammation, Autoimmune Research, published in Biomedicines (2025) — summary generated from the PubMed abstract.
- 2025
Biomedicines5 citations - Level DNarrative ReviewPubMed
"Remodeling the intestinal immune microenvironment": immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease.
Narrative Review on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol - Level DNarrative ReviewPubMed
Mesenchymal stem/stromal cells-derived exosomes: possible therapeutic mechanism in inflammatory bowel disease.
Narrative Review on Ligament Injury, Chronic Inflammation, Immune Modulation, published in Hum Cell (2025) — summary generated from the PubMed abstract.
- 2025
Hum Cell - Level DNarrative ReviewEurope PMC
Mechanism of cell death and its application in the repair of inflammatory bowel disease by mesenchymal stem cells
Narrative Review on Autoimmune Research, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol1 citations - Level DNarrative ReviewEurope PMC
Advances of exosome regulating‑FXR to repair inflammatory bowel disease (Review)
Narrative Review on Autoimmune Research, published in Int J Mol Med (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Med2 citations - Level DNarrative ReviewEurope PMC
Two sides of the same coin: protective versus pathogenic mesentery in inflammatory bowel diseases - a comprehensive review
Narrative Review on Chronic Inflammation, Autoimmune Research, published in Int J Surg (2025) — summary generated from the PubMed abstract.
- 2025
Int J Surg3 citations - Level DLaboratory StudyPubMed
3D-Printed core-shell tablet for effective oral delivery of AT-MSC secretome in inflammatory bowel disease therapy.
Laboratory Study on Immune Modulation, published in Drug Deliv Transl Res (2025) — summary generated from the PubMed abstract.
- 2025
Drug Deliv Transl Res - Level DNarrative ReviewEurope PMC
Succinate metabolism: underlying biological mechanisms and emerging therapeutic targets in inflammatory bowel disease
Narrative Review on Face & Skin, Systemic / IV, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol3 citations - Level BClinical TrialPubMed
Improved efficacy and long-term protective effects of CXCR4/IL10 bioengineered mesenchymal stromal cells in a model of inflammatory bowel disease.
Clinical Trial on Immune Modulation, published in Bioeng Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
Bioeng Transl Med - Level BClinical TrialPubMed
Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Vet J (2024) — summary generated from the PubMed abstract.
- 2024
Vet J - Level DLaboratory StudyEurope PMC
Monocytes Count, NLR, MLR and PLR in Canine Inflammatory Bowel Disease
Laboratory Study, published in Animals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Animals (Basel)13 citations - Level DAnimal StudyPubMed
Etanercept-synthesizing adipose-derived stem cell secretome: A promising therapeutic option for inflammatory bowel disease.
Animal Study on Chronic Inflammation, published in World J Gastrointest Surg (2024) — summary generated from the PubMed abstract.
- 2024
World J Gastrointest Surg - Level BClinical TrialPubMed
Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease.
Clinical Trial on Immune Modulation, published in Inflammopharmacology (2024) — summary generated from the PubMed abstract.
- 2024
Inflammopharmacology - Level DNarrative ReviewEurope PMC
A Comprehensive Exploration of Therapeutic Strategies in Inflammatory Bowel Diseases: Insights from Human and Animal Studies
Narrative Review on Immune Modulation, published in Biomedicines (2024) — summary generated from the PubMed abstract.
- 2024
Biomedicines8 citations - Level DNarrative ReviewEurope PMC
Research advancements and perspectives of inflammatory bowel disease: A comprehensive review
Narrative Review on Immune Modulation, Autoimmune Research, published in Sci Prog (2024) — summary generated from the PubMed abstract.
- 2024
Sci Prog7 citations - Level DNarrative ReviewEurope PMC
Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
Narrative Review on Immune Modulation, published in Pharmaceuticals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Pharmaceuticals (Basel)17 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406